Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Vaishali Pharma Ltd. ( (IN:VAISHALI) ) just unveiled an announcement.
Vaishali Pharma Ltd. has announced changes in its management structure following a postal ballot where shareholders approved the appointment of Mr. Bhaveshkumar Popatlal Upadhyay as a Non-Executive Independent Director and the re-appointment of Mr. Manish Bhagwandas Ved as an Independent Director for another five-year term. These appointments are expected to strengthen the company’s leadership team, leveraging Mr. Upadhyay’s extensive experience in business and HR management within the pharmaceutical industry, potentially enhancing the company’s strategic positioning and operational effectiveness.
More about Vaishali Pharma Ltd.
Vaishali Pharma Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is engaged in providing a wide range of healthcare solutions and has a market focus on expanding its presence in the pharmaceutical sector.
YTD Price Performance: -23.01%
Average Trading Volume: 647,860
Current Market Cap: 1.47B INR
See more data about VAISHALI stock on TipRanks’ Stock Analysis page.